HTA92 Diffusion and launch sequencing of cell and gene therapies across the USA, Europe, Canada and Australia
Bergsteedt, M., Tolkmitt, F., Mills, M. & Kanavos, P.
(2025).
HTA92 Diffusion and launch sequencing of cell and gene therapies across the USA, Europe, Canada and Australia.
Value in Health,
28(6, Supplement 1), S263 - S264.
https://doi.org/10.1016/j.jval.2025.04.1103
(2025).
HTA92 Diffusion and launch sequencing of cell and gene therapies across the USA, Europe, Canada and Australia.
Value in Health,
28(6, Supplement 1), S263 - S264.
https://doi.org/10.1016/j.jval.2025.04.1103
Cell and gene therapies (CGTs) represent a significant advancement in healthcare, providing potential cures for previously untreatable conditions. However, they often carry high prices and their availability across settings remains mixed. This study examines the diffusion of FDA approved CGTs in Canada, Australia, France, Germany, England and Scotland.